Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.20 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)452.48K
Market Cap
$1.54B
Enterprise Value$1.11B
Total Cash (Recent Filing)$342.12M
Total Debt (Recent Filing)$29.39M
Price to Earnings (P/E)59.7
Beta1.18
Next Earnings
Oct 30, 2025EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding49,927,530
10 Day Avg. Volume349,453
30 Day Avg. Volume452,477
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit3.98
Enterprise Value/Ebitda9.89
Forecast
1Y Price Target
$41.40Price Target Upside34.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
AcquisitionThe Prospect Health acquisition closed at a lower purchase price than initially expected, allowing a lower pro-forma net leverage ratio.
Financial PerformanceAstrana Health reported second quarter 2025 results with sales ahead of expectations and adjusted EBITDA topping the consensus forecast.
Bears Say
Market SkepticismThe market remains skeptical about the Prospect acquisition, and doubters need to see performance post-close to be convinced.
Regulatory ImpactsThe Big Beautiful Bill Act could lead to a $200-$250M revenue headwind on a lower-margin book of business.
Astrana Health News
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $21.20 and its highest was $63.20 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.54B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Oct 30, 2025 which is in 54 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Aug 07, 2025. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.349 by -$0.159.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.47.
How many shares outstanding does Astrana Health have?
Astrana Health has 49,927,530 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of $0.19 in its last earnings report, missing expectations of $0.349. Following the earnings report the stock price went up 30.848%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.40 (34.33% Upside)
$41.40 (34.33% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 233.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.53%
12-Months-Change
Fundamentals
Return on Equity
3.50%
Trailing 12-Months
Asset Growth
15.16%
Trailing 12-Months
Company Description
Astrana Health
Astrana Health (ASTH) is a healthcare technology company focused on providing innovative solutions that enhance patient care and streamline healthcare operations. Operating primarily in the health tech sector, Astrana Health develops a suite of digital health products, including telehealth platforms, electronic health record (EHR) systems, and data analytics tools designed to improve healthcare delivery and outcomes across various medical specialties.
ASTH Company Deck
ASTH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call showcased strong financial performance, highlighted by significant revenue growth and a successful acquisition that improved their leverage position. The company maintained high adjusted EBITDA and increased revenue from full risk contracts, reinforcing its profitability. However, challenges remain, primarily due to Medicaid cost trends and exposure to regulatory changes in Medicaid and health insurance exchanges. Despite these concerns, the overall sentiment is positive given the company's strong execution and strategic advancements.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$41.40
▲(34.33% Upside)
Technical Analysis
Addus Homecare
―
Pediatrix Medical Group
―
National Healthcare
―
Agilon Health
―
Ardent Health Partners, Inc.
―
Ownership Overview
47.42% Insiders
18.08% Mutual Funds
7.92% Other Institutional Investors
5.32% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---